These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

349 related items for PubMed ID: 26033547

  • 1. Serum levels of GFAP and EGFR in primary and recurrent high-grade gliomas: correlation to tumor volume, molecular markers, and progression-free survival.
    Kiviniemi A, Gardberg M, Frantzén J, Parkkola R, Vuorinen V, Pesola M, Minn H.
    J Neurooncol; 2015 Sep; 124(2):237-45. PubMed ID: 26033547
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. In vitro neurosphere formation correlates with poor survival in glioma.
    C Jayakrishnan P, H Venkat E, M Ramachandran G, K Kesavapisharady K, N Nair S, Bharathan B, Radhakrishnan N, Gopala S.
    IUBMB Life; 2019 Feb; 71(2):244-253. PubMed ID: 30393962
    [Abstract] [Full Text] [Related]

  • 4. Pre- and post-operative plasma glial fibrillary acidic protein levels in patients with newly diagnosed gliomas.
    Husain H, Savage W, Grossman SA, Ye X, Burger PC, Everett A, Bettegowda C, Diaz LA, Blair C, Romans KE, Holdhoff M.
    J Neurooncol; 2012 Aug; 109(1):123-7. PubMed ID: 22492246
    [Abstract] [Full Text] [Related]

  • 5. Corpus callosum involvement and postoperative outcomes of patients with gliomas.
    Chen KT, Wu TW, Chuang CC, Hsu YH, Hsu PW, Huang YC, Lin TK, Chang CN, Lee ST, Wu CT, Tseng CK, Wang CC, Pai PC, Wei KC, Chen PY.
    J Neurooncol; 2015 Sep; 124(2):207-14. PubMed ID: 26033546
    [Abstract] [Full Text] [Related]

  • 6. Pre- and early postoperative GFAP serum levels in glioma and brain metastases.
    Baumgarten P, Quick-Weller J, Gessler F, Wagner M, Tichy J, Forster MT, Foerch C, Seifert V, Mittelbronn M, Senft C.
    J Neurooncol; 2018 Sep; 139(3):541-546. PubMed ID: 29797180
    [Abstract] [Full Text] [Related]

  • 7. Serum concentrations of glial fibrillary acidic protein (GFAP) do not indicate tumor recurrence in patients with glioblastoma.
    Vietheer JM, Rieger J, Wagner M, Senft C, Tichy J, Foerch C.
    J Neurooncol; 2017 Oct; 135(1):193-199. PubMed ID: 28717884
    [Abstract] [Full Text] [Related]

  • 8. Prospective evaluation of serum glial fibrillary acidic protein (GFAP) as a diagnostic marker for glioblastoma.
    Tichy J, Spechtmeyer S, Mittelbronn M, Hattingen E, Rieger J, Senft C, Foerch C.
    J Neurooncol; 2016 Jan; 126(2):361-9. PubMed ID: 26518540
    [Abstract] [Full Text] [Related]

  • 9. Serum GFAP is a diagnostic marker for glioblastoma multiforme.
    Jung CS, Foerch C, Schänzer A, Heck A, Plate KH, Seifert V, Steinmetz H, Raabe A, Sitzer M.
    Brain; 2007 Dec; 130(Pt 12):3336-41. PubMed ID: 17998256
    [Abstract] [Full Text] [Related]

  • 10. Volumetric Analysis of Extent of Resection, Survival, and Surgical Outcomes for Insular Gliomas.
    Eseonu CI, ReFaey K, Garcia O, Raghuraman G, Quinones-Hinojosa A.
    World Neurosurg; 2017 Jul; 103():265-274. PubMed ID: 28408263
    [Abstract] [Full Text] [Related]

  • 11. Diagnostic and prognostic value of preoperative combined GFAP, IGFBP-2, and YKL-40 plasma levels in patients with glioblastoma.
    Gállego Pérez-Larraya J, Paris S, Idbaih A, Dehais C, Laigle-Donadey F, Navarro S, Capelle L, Mokhtari K, Marie Y, Sanson M, Hoang-Xuan K, Delattre JY, Mallet A.
    Cancer; 2014 Dec 15; 120(24):3972-80. PubMed ID: 25139333
    [Abstract] [Full Text] [Related]

  • 12. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
    Sanai N, Polley MY, Berger MS.
    J Neurosurg; 2010 Jan 15; 112(1):1-9. PubMed ID: 19612970
    [Abstract] [Full Text] [Related]

  • 13. Surgery for Recurrent High-Grade Glioma After Treatment with Bevacizumab.
    Blumenthal DT, Kanner AA, Aizenstein O, Cagnano E, Greenberg A, Hershkovitz D, Ram Z, Bokstein F.
    World Neurosurg; 2018 Feb 15; 110():e727-e737. PubMed ID: 29183864
    [Abstract] [Full Text] [Related]

  • 14. The role of the epidermal growth factor receptor in human gliomas: II. The control of glial process extension and the expression of glial fibrillary acidic protein.
    Hoi Sang U, Espiritu OD, Kelley PY, Klauber MR, Hatton JD.
    J Neurosurg; 1995 May 15; 82(5):847-57. PubMed ID: 7714612
    [Abstract] [Full Text] [Related]

  • 15. Recurrent pediatric central nervous system low-grade gliomas: the role of surveillance neuroimaging in asymptomatic children.
    Udaka YT, Yeh-Nayre LA, Amene CS, VandenBerg SR, Levy ML, Crawford JR.
    J Neurosurg Pediatr; 2013 Feb 15; 11(2):119-26. PubMed ID: 23157391
    [Abstract] [Full Text] [Related]

  • 16. Altered galectin-1 serum levels in patients diagnosed with high-grade glioma.
    Verschuere T, Van Woensel M, Fieuws S, Lefranc F, Mathieu V, Kiss R, Van Gool SW, De Vleeschouwer S.
    J Neurooncol; 2013 Oct 15; 115(1):9-17. PubMed ID: 23824536
    [Abstract] [Full Text] [Related]

  • 17. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K, Wijnenga MM, Weenink B, Gao Y, Smid M, Robe P, van den Bent MJ, French PJ.
    Acta Neuropathol Commun; 2015 Dec 23; 3():88. PubMed ID: 26699864
    [Abstract] [Full Text] [Related]

  • 18. Low preoperative prognostic nutritional index predicts poor survival in patients with newly diagnosed high-grade gliomas.
    He ZQ, Ke C, Al-Nahari F, Duan H, Guo CC, Wang Y, Zhang XH, Chen YS, Liu ZG, Wang J, Chen ZP, Jiang XB, Mou YG.
    J Neurooncol; 2017 Apr 23; 132(2):239-247. PubMed ID: 28078639
    [Abstract] [Full Text] [Related]

  • 19. Pathological significance of epidermal growth factor receptor expression and amplification in human gliomas.
    Zhao LL, Xu KL, Wang SW, Hu BL, Chen LR.
    Histopathology; 2012 Oct 23; 61(4):726-36. PubMed ID: 22978472
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.